Mechanism of Action of Fingolimod
Introduction Fingolimod is an oral disease-modifying drug used in relapsing forms of multiple sclerosis. It was originally marketed under the brand name Gilenya. Pharmacologically, fingolimod is a sphingosine 1-phosphate receptor modulator, commonly called an S1P receptor modulator. Multiple sclerosis is an immune-mediated demyelinating disease of the central nervous system. In MS, autoreactive lymphocytes cross the … Read more